A.D. Roth

Discipline

Psychologie (1)

Type de document

Articles (9)

Co-auteur

Date

Source

Mot-clé

survie (8) Survival (8) Human beings (8) procès (7) Tumors (6) Prognosis (6) Patients (6) Prognosis (6) Patients (6) Treatment (5) Chemotherapy (5) Theater (5) Drama (5) Colon (Anatomy)--Cancer (5) Chemotherapy (5) Acting (5) maladie (4) adulte (4) Methods (4) Rectum--Cancer (4) Theaters--Stage-setting and scenery (4) Months (4) Cycles (4) Older people (4) Methods (4) adulte (4) maladie (4) puits (3) toxicité (3) temps (durée) (3)

Documents écrit par A.D. Roth (9) | parle de A.D. Roth (0)

Response.
M. Delorenzi et al. (2015)
Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial?.
D. Klingbiel et al. (2015)
Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer.
V. Popovici et al. (27 sept. 2013)
A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations.
T. Xie et al. (2012)
Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzle.
S. Tejpar et al. (2011)
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
W. Weder et al. (2007)
Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study.
D.C. Betticher et al. (2006)
Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study
Y. Seium et al.
5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trial
A. D. Roth et al.